Extrapulmonary infection is rare in cystic fibrosis. We describe two adult patients with cystic fibrosis whose course was complicated by the development of liver abscesses. The possible aetiology of these abscesses is discussed and the diagnosis, treatment and prognosis of pyogenic hepatic abscess is briefly reviewed.
Introduction
Almost all patients with cystic fibrosis (CF) eventually develop chronic pulmonary infection with specific bacterial pathogens, notably Pseudomonas species and Staphylococcus aureus.1 Despite this, the development of septicaemia2'3 or metastatic infection4-6 has rarely been described in the disease. The present report describes two adults with CF whose course was complicated by the development of liver abscesses.
Case reports Case I This 20 year old male was diagnosed as having CF at 3 months of age, based on evidence for pancreatic insufficiency and elevated sweat chloride values. Progressive pulmonary deterioration was noted from the age of 5 years, and during this period of time he required frequent courses of parenteral antibiotic therapy for pulmonary exacerbations. At revealed two space-occupying lesions, one located in the left lobe, the other in the right lobe of the liver: no gall stones were visualized. This finding was confirmed by CT scan (Figure 2 ). Under CT guidance 2ml of serosanguinous material was aspirated from the lesion in the left lobe of the liver, and I ml from the right lobe lesion. Histological examination of this material revealed neutrophils mixed with red blood cells; no parasites were visualized, and all cultures were sterile. Blood cultures were also repeatedly negative. The antibiotic regimen was changed to gentamicin and metronidazole and continued for 4 weeks. On discharge from hospital, an ultrasound examination revealed considerable reduction in the size of both liver lesions, and a repeat ultrasound 3 months later showed complete resolution of these lesions.
Discussion
Pyogenic hepatic abscess is an uncommon problem in both adults7 and children,8 particularly in patients with normal immune mechanisms. The cases presented are of interest because of the rarity of extrapulmonary infections in CF patients. Although liver involvement is relatively common in CF, to our knowledge hepatic abscess has not previously been deqcribed in association with the disease. Unfortunately, the source of infection in each of our patients was unclear. Bacterial infection may become established in the liver in several ways, including through biliary sepsis, trauma, direct extension from infection of contiguous structures, or infection in abdominal viscera drained by the portal vein. None of these pathogenic mechanisms, however, applied in either of our patients. It is tempting to speculate that the hepatic abscesses in the patients described resulted from systemic septicaemia, arising from the lower respiratory tract. Pneumonia as a source of septicaemia, leading to the development of hepatic abscess has previously been described.8 Although rare, bacteraemia can occur in CF2'3 and recently the development of brain abscess has been described in adult patients with CF,4 6 the source of which was presumed to be septicaemia related to bronchiectatic lung disease.4 In our patients it is possible that a small area of hepatic necrosis may have provided a nidus for infection. Alternatively, the patients may have had asymptomatic congenital liver cysts which became superinfected in the course of bacteraemia, and this might explain the occurrence of liver abscess in two siblings. However, we have no direct evidence that either of these mechanisms applied to our patients, as numerous blood cultures, and culture of the material aspirated from the liver abscesses were sterile in both cases, possibly reflecting prior parenteral antibiotic therapy. This finding of sterile cultures of blood and of pus obtained from liver abscesses is not unusual, as attested by recent reviews of the subject.9"l0 The absence of a documented septicaemic illness and the failure to isolate similar organisms from the lung and from the liver abscesses in our patients, suggest that these abscesses were most likely cryptogenic in nature, i.e. abscesses for which no source of infection can be determined.7 '8 The diagnosis of hepatic abscess is frequently not made during life, both because of the rarity of the lesion and its non-specific clinical presentation.78
However, in recent years the diagnosis and precise localization of liver abscess has been facilitated by the advent of newer imaging techniques, ultrasonography and CT in particular.9-17 These techniques have also revolutionized the management of hepatic abscess. Thus, although transperitoneal surgical drainage has been the traditional treatment,7 recently percutaneous aspiration, guided by CT or ultrasound, has increasingly replaced open drainage both in children and adults with hepatic abscess.9-1" Although percutaneous drainage is not universally successful,'7 we opted for this approach, as both our patients were considered poor surgical risks in view of advanced lung disease. Irrespective of whether an open or closed drainage procedure is used, all patients with hepatic abscess should receive parenteral antibiotic therapy.910 12 -15 Whilst awaiting culture results, an empiric antibiotic regimen should be chosen that will cover the pathogens most frequently isolated from hepatic abscess, namely Gram-negative bacilli and anaerobes. 7 The optimal duration of antibiotic therapy is not known, but a minimum of 4-8 weeks is generally recommended.7 Finally, despite recent advances in diagnostic methods and approaches to treatment, pyogenic liver abscess is still associated with a substantial mortality. 15 Craig et al. 12 recently attempted to identify prognostic factors with respect to pyogenic liver abscesses. These investigators found that, with appropriate antibiotic therapy and drainage, patients like ours who present with 1-2 abscesses and have no evidence of jaundice or biliary obstruction generally have a good prognosis.
